China Pharma Holdings, Inc.
China Pharma Holdings, Inc. CPHI Peers
See (CPHI) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CPHI | $2.23 | -5.11% | 7.27M | -0.78 | -$2.86 | N/A |
| ZTS | $163.09 | +1.71% | 72.61B | 29.33 | $5.56 | +1.14% |
| HLN | $10.80 | +1.22% | 48.71B | 25.71 | $0.42 | +1.56% |
| TAK | $14.10 | +0.71% | 44.38B | 61.30 | $0.23 | +4.18% |
| TEVA | $16.95 | +0.44% | 19.42B | -14.73 | -$1.15 | N/A |
| ITCI | $131.87 | N/A | 14.05B | -180.64 | -$0.73 | N/A |
| RDY | $14.45 | +0.38% | 12.03B | 18.06 | $0.80 | +0.66% |
| NBIX | $121.02 | +0.62% | 11.98B | 41.02 | $2.95 | N/A |
| CTLT | $63.48 | N/A | 11.52B | -27.84 | -$2.28 | N/A |
| VTRS | $8.84 | +0.57% | 10.38B | -2.78 | -$3.18 | +5.43% |
Stock Comparison
CPHI vs ZTS Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, ZTS has a market cap of 72.61B. Regarding current trading prices, CPHI is priced at $2.23, while ZTS trades at $163.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas ZTS's P/E ratio is 29.33. In terms of profitability, CPHI's ROE is -0.45%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, CPHI is more volatile compared to ZTS. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs HLN Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, HLN has a market cap of 48.71B. Regarding current trading prices, CPHI is priced at $2.23, while HLN trades at $10.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas HLN's P/E ratio is 25.71. In terms of profitability, CPHI's ROE is -0.45%, compared to HLN's ROE of +0.09%. Regarding short-term risk, CPHI is more volatile compared to HLN. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs TAK Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, TAK has a market cap of 44.38B. Regarding current trading prices, CPHI is priced at $2.23, while TAK trades at $14.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas TAK's P/E ratio is 61.30. In terms of profitability, CPHI's ROE is -0.45%, compared to TAK's ROE of +0.04%. Regarding short-term risk, CPHI is more volatile compared to TAK. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs TEVA Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, TEVA has a market cap of 19.42B. Regarding current trading prices, CPHI is priced at $2.23, while TEVA trades at $16.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas TEVA's P/E ratio is -14.73. In terms of profitability, CPHI's ROE is -0.45%, compared to TEVA's ROE of -0.21%. Regarding short-term risk, CPHI is more volatile compared to TEVA. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs ITCI Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, ITCI has a market cap of 14.05B. Regarding current trading prices, CPHI is priced at $2.23, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas ITCI's P/E ratio is -180.64. In terms of profitability, CPHI's ROE is -0.45%, compared to ITCI's ROE of -0.07%. Regarding short-term risk, CPHI is more volatile compared to ITCI. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs RDY Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, RDY has a market cap of 12.03B. Regarding current trading prices, CPHI is priced at $2.23, while RDY trades at $14.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas RDY's P/E ratio is 18.06. In terms of profitability, CPHI's ROE is -0.45%, compared to RDY's ROE of +0.18%. Regarding short-term risk, CPHI is more volatile compared to RDY. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs NBIX Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, NBIX has a market cap of 11.98B. Regarding current trading prices, CPHI is priced at $2.23, while NBIX trades at $121.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas NBIX's P/E ratio is 41.02. In terms of profitability, CPHI's ROE is -0.45%, compared to NBIX's ROE of +0.12%. Regarding short-term risk, CPHI is more volatile compared to NBIX. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs CTLT Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, CTLT has a market cap of 11.52B. Regarding current trading prices, CPHI is priced at $2.23, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas CTLT's P/E ratio is -27.84. In terms of profitability, CPHI's ROE is -0.45%, compared to CTLT's ROE of -0.11%. Regarding short-term risk, CPHI is more volatile compared to CTLT. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs VTRS Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, VTRS has a market cap of 10.38B. Regarding current trading prices, CPHI is priced at $2.23, while VTRS trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas VTRS's P/E ratio is -2.78. In terms of profitability, CPHI's ROE is -0.45%, compared to VTRS's ROE of -0.21%. Regarding short-term risk, CPHI is more volatile compared to VTRS. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs ELAN Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, ELAN has a market cap of 6.42B. Regarding current trading prices, CPHI is priced at $2.23, while ELAN trades at $12.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas ELAN's P/E ratio is 17.23. In terms of profitability, CPHI's ROE is -0.45%, compared to ELAN's ROE of +0.06%. Regarding short-term risk, CPHI is more volatile compared to ELAN. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs LNTH Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, LNTH has a market cap of 5.62B. Regarding current trading prices, CPHI is priced at $2.23, while LNTH trades at $81.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas LNTH's P/E ratio is 23.15. In terms of profitability, CPHI's ROE is -0.45%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, CPHI is more volatile compared to LNTH. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs RGC Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, RGC has a market cap of 5.08B. Regarding current trading prices, CPHI is priced at $2.23, while RGC trades at $390.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas RGC's P/E ratio is -1115.57. In terms of profitability, CPHI's ROE is -0.45%, compared to RGC's ROE of -0.25%. Regarding short-term risk, CPHI is less volatile compared to RGC. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs PRGO Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, PRGO has a market cap of 3.72B. Regarding current trading prices, CPHI is priced at $2.23, while PRGO trades at $27.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas PRGO's P/E ratio is -22.53. In terms of profitability, CPHI's ROE is -0.45%, compared to PRGO's ROE of -0.04%. Regarding short-term risk, CPHI is more volatile compared to PRGO. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs AMRX Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, AMRX has a market cap of 3.54B. Regarding current trading prices, CPHI is priced at $2.23, while AMRX trades at $7.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas AMRX's P/E ratio is -190.00. In terms of profitability, CPHI's ROE is -0.45%, compared to AMRX's ROE of -0.00%. Regarding short-term risk, CPHI is more volatile compared to AMRX. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs ALVOW Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, ALVOW has a market cap of 3.17B. Regarding current trading prices, CPHI is priced at $2.23, while ALVOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas ALVOW's P/E ratio is N/A. In terms of profitability, CPHI's ROE is -0.45%, compared to ALVOW's ROE of -0.23%. Regarding short-term risk, CPHI is less volatile compared to ALVOW. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs ALVO Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, ALVO has a market cap of 3.16B. Regarding current trading prices, CPHI is priced at $2.23, while ALVO trades at $10.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas ALVO's P/E ratio is 28.27. In terms of profitability, CPHI's ROE is -0.45%, compared to ALVO's ROE of -0.23%. Regarding short-term risk, CPHI is more volatile compared to ALVO. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs HCM Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, HCM has a market cap of 2.36B. Regarding current trading prices, CPHI is priced at $2.23, while HCM trades at $13.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas HCM's P/E ratio is 66.95. In terms of profitability, CPHI's ROE is -0.45%, compared to HCM's ROE of +0.05%. Regarding short-term risk, CPHI is more volatile compared to HCM. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs DCPH Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, DCPH has a market cap of 2.21B. Regarding current trading prices, CPHI is priced at $2.23, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas DCPH's P/E ratio is -11.58. In terms of profitability, CPHI's ROE is -0.45%, compared to DCPH's ROE of -0.52%. Regarding short-term risk, CPHI is more volatile compared to DCPH. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs EMBCV Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, EMBCV has a market cap of 1.91B. Regarding current trading prices, CPHI is priced at $2.23, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas EMBCV's P/E ratio is N/A. In terms of profitability, CPHI's ROE is -0.45%, compared to EMBCV's ROE of -0.07%. Regarding short-term risk, CPHI is less volatile compared to EMBCV. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs SUPN Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, SUPN has a market cap of 1.87B. Regarding current trading prices, CPHI is priced at $2.23, while SUPN trades at $33.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas SUPN's P/E ratio is 30.12. In terms of profitability, CPHI's ROE is -0.45%, compared to SUPN's ROE of +0.06%. Regarding short-term risk, CPHI is more volatile compared to SUPN. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs BGM Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, BGM has a market cap of 1.83B. Regarding current trading prices, CPHI is priced at $2.23, while BGM trades at $12.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas BGM's P/E ratio is -62.70. In terms of profitability, CPHI's ROE is -0.45%, compared to BGM's ROE of N/A. Regarding short-term risk, CPHI is less volatile compared to BGM. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs BHC Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, BHC has a market cap of 1.73B. Regarding current trading prices, CPHI is priced at $2.23, while BHC trades at $4.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas BHC's P/E ratio is -38.96. In terms of profitability, CPHI's ROE is -0.45%, compared to BHC's ROE of +0.05%. Regarding short-term risk, CPHI is more volatile compared to BHC. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs TARO Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, TARO has a market cap of 1.62B. Regarding current trading prices, CPHI is priced at $2.23, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas TARO's P/E ratio is 30.05. In terms of profitability, CPHI's ROE is -0.45%, compared to TARO's ROE of +0.03%. Regarding short-term risk, CPHI is more volatile compared to TARO. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs EVO Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, EVO has a market cap of 1.44B. Regarding current trading prices, CPHI is priced at $2.23, while EVO trades at $4.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas EVO's P/E ratio is -6.44. In terms of profitability, CPHI's ROE is -0.45%, compared to EVO's ROE of -0.22%. Regarding short-term risk, CPHI is more volatile compared to EVO. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs INDV Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, INDV has a market cap of 1.41B. Regarding current trading prices, CPHI is priced at $2.23, while INDV trades at $11.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas INDV's P/E ratio is -226.80. In terms of profitability, CPHI's ROE is -0.45%, compared to INDV's ROE of -0.01%. Regarding short-term risk, CPHI is more volatile compared to INDV. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs ANIP Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, ANIP has a market cap of 1.30B. Regarding current trading prices, CPHI is priced at $2.23, while ANIP trades at $59.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas ANIP's P/E ratio is -50.84. In terms of profitability, CPHI's ROE is -0.45%, compared to ANIP's ROE of -0.05%. Regarding short-term risk, CPHI is more volatile compared to ANIP. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs PCRX Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, PCRX has a market cap of 1.20B. Regarding current trading prices, CPHI is priced at $2.23, while PCRX trades at $25.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas PCRX's P/E ratio is -11.54. In terms of profitability, CPHI's ROE is -0.45%, compared to PCRX's ROE of -0.13%. Regarding short-term risk, CPHI is more volatile compared to PCRX. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs AMPH Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, AMPH has a market cap of 1.17B. Regarding current trading prices, CPHI is priced at $2.23, while AMPH trades at $24.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas AMPH's P/E ratio is 9.01. In terms of profitability, CPHI's ROE is -0.45%, compared to AMPH's ROE of +0.19%. Regarding short-term risk, CPHI is more volatile compared to AMPH. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs DVAX Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, DVAX has a market cap of 1.16B. Regarding current trading prices, CPHI is priced at $2.23, while DVAX trades at $9.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas DVAX's P/E ratio is -19.34. In terms of profitability, CPHI's ROE is -0.45%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, CPHI is more volatile compared to DVAX. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs HROW Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, HROW has a market cap of 1.04B. Regarding current trading prices, CPHI is priced at $2.23, while HROW trades at $28.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas HROW's P/E ratio is -46.57. In terms of profitability, CPHI's ROE is -0.45%, compared to HROW's ROE of -0.36%. Regarding short-term risk, CPHI is less volatile compared to HROW. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs PAHC Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, PAHC has a market cap of 972.81M. Regarding current trading prices, CPHI is priced at $2.23, while PAHC trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas PAHC's P/E ratio is 30.77. In terms of profitability, CPHI's ROE is -0.45%, compared to PAHC's ROE of +0.12%. Regarding short-term risk, CPHI is more volatile compared to PAHC. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs COLL Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, COLL has a market cap of 971.66M. Regarding current trading prices, CPHI is priced at $2.23, while COLL trades at $30.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas COLL's P/E ratio is 24.78. In terms of profitability, CPHI's ROE is -0.45%, compared to COLL's ROE of +0.19%. Regarding short-term risk, CPHI is more volatile compared to COLL. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs PETQ Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, PETQ has a market cap of 919.17M. Regarding current trading prices, CPHI is priced at $2.23, while PETQ trades at $30.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas PETQ's P/E ratio is 83.73. In terms of profitability, CPHI's ROE is -0.45%, compared to PETQ's ROE of +0.06%. Regarding short-term risk, CPHI is more volatile compared to PETQ. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs AVDL Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, AVDL has a market cap of 871.62M. Regarding current trading prices, CPHI is priced at $2.23, while AVDL trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas AVDL's P/E ratio is -34.65. In terms of profitability, CPHI's ROE is -0.45%, compared to AVDL's ROE of -0.36%. Regarding short-term risk, CPHI is more volatile compared to AVDL. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs CRON Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, CRON has a market cap of 824.80M. Regarding current trading prices, CPHI is priced at $2.23, while CRON trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas CRON's P/E ratio is 15.29. In terms of profitability, CPHI's ROE is -0.45%, compared to CRON's ROE of +0.05%. Regarding short-term risk, CPHI is more volatile compared to CRON. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs EMBC Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, EMBC has a market cap of 702.48M. Regarding current trading prices, CPHI is priced at $2.23, while EMBC trades at $12.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas EMBC's P/E ratio is 13.51. In terms of profitability, CPHI's ROE is -0.45%, compared to EMBC's ROE of -0.07%. Regarding short-term risk, CPHI is more volatile compared to EMBC. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs EOLS Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, EOLS has a market cap of 625.41M. Regarding current trading prices, CPHI is priced at $2.23, while EOLS trades at $9.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas EOLS's P/E ratio is -10.90. In terms of profitability, CPHI's ROE is -0.45%, compared to EOLS's ROE of -9.32%. Regarding short-term risk, CPHI is more volatile compared to EOLS. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs BDSI Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, BDSI has a market cap of 577.05M. Regarding current trading prices, CPHI is priced at $2.23, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas BDSI's P/E ratio is 6.82. In terms of profitability, CPHI's ROE is -0.45%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, CPHI is more volatile compared to BDSI. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs TLRY Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, TLRY has a market cap of 507.64M. Regarding current trading prices, CPHI is priced at $2.23, while TLRY trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas TLRY's P/E ratio is -0.45. In terms of profitability, CPHI's ROE is -0.45%, compared to TLRY's ROE of -0.29%. Regarding short-term risk, CPHI is less volatile compared to TLRY. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs KMDA Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, KMDA has a market cap of 399.08M. Regarding current trading prices, CPHI is priced at $2.23, while KMDA trades at $6.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas KMDA's P/E ratio is 27.76. In terms of profitability, CPHI's ROE is -0.45%, compared to KMDA's ROE of +0.06%. Regarding short-term risk, CPHI is more volatile compared to KMDA. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs ORGO Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, ORGO has a market cap of 390.71M. Regarding current trading prices, CPHI is priced at $2.23, while ORGO trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas ORGO's P/E ratio is -19.25. In terms of profitability, CPHI's ROE is -0.45%, compared to ORGO's ROE of -0.06%. Regarding short-term risk, CPHI is more volatile compared to ORGO. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs SIGA Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, SIGA has a market cap of 390.58M. Regarding current trading prices, CPHI is priced at $2.23, while SIGA trades at $5.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas SIGA's P/E ratio is 4.56. In terms of profitability, CPHI's ROE is -0.45%, compared to SIGA's ROE of +0.25%. Regarding short-term risk, CPHI is more volatile compared to SIGA. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs ZYBT Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, ZYBT has a market cap of 371.55M. Regarding current trading prices, CPHI is priced at $2.23, while ZYBT trades at $7.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas ZYBT's P/E ratio is 130.67. In terms of profitability, CPHI's ROE is -0.45%, compared to ZYBT's ROE of N/A. Regarding short-term risk, CPHI is less volatile compared to ZYBT. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs EBS Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, EBS has a market cap of 361.37M. Regarding current trading prices, CPHI is priced at $2.23, while EBS trades at $6.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas EBS's P/E ratio is -2.58. In terms of profitability, CPHI's ROE is -0.45%, compared to EBS's ROE of -0.27%. Regarding short-term risk, CPHI is less volatile compared to EBS. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs TKNO Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, TKNO has a market cap of 353.51M. Regarding current trading prices, CPHI is priced at $2.23, while TKNO trades at $6.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas TKNO's P/E ratio is -14.38. In terms of profitability, CPHI's ROE is -0.45%, compared to TKNO's ROE of -0.28%. Regarding short-term risk, CPHI is more volatile compared to TKNO. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs SNDL Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, SNDL has a market cap of 347.36M. Regarding current trading prices, CPHI is priced at $2.23, while SNDL trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas SNDL's P/E ratio is -4.66. In terms of profitability, CPHI's ROE is -0.45%, compared to SNDL's ROE of -0.09%. Regarding short-term risk, CPHI is more volatile compared to SNDL. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs ALIM Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, ALIM has a market cap of 301.29M. Regarding current trading prices, CPHI is priced at $2.23, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas ALIM's P/E ratio is 5.28. In terms of profitability, CPHI's ROE is -0.45%, compared to ALIM's ROE of -0.34%. Regarding short-term risk, CPHI is more volatile compared to ALIM. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs CGC Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, CGC has a market cap of 298.93M. Regarding current trading prices, CPHI is priced at $2.23, while CGC trades at $1.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas CGC's P/E ratio is -0.46. In terms of profitability, CPHI's ROE is -0.45%, compared to CGC's ROE of -0.88%. Regarding short-term risk, CPHI is less volatile compared to CGC. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs ACB Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, ACB has a market cap of 281.56M. Regarding current trading prices, CPHI is priced at $2.23, while ACB trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas ACB's P/E ratio is 27.00. In terms of profitability, CPHI's ROE is -0.45%, compared to ACB's ROE of -0.06%. Regarding short-term risk, CPHI is more volatile compared to ACB. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs LNDC Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, LNDC has a market cap of 263.63M. Regarding current trading prices, CPHI is priced at $2.23, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas LNDC's P/E ratio is -4.04. In terms of profitability, CPHI's ROE is -0.45%, compared to LNDC's ROE of +2.28%. Regarding short-term risk, CPHI is more volatile compared to LNDC. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs LFCR Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, LFCR has a market cap of 255.29M. Regarding current trading prices, CPHI is priced at $2.23, while LFCR trades at $6.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas LFCR's P/E ratio is -4.69. In terms of profitability, CPHI's ROE is -0.45%, compared to LFCR's ROE of -2.64%. Regarding short-term risk, CPHI is more volatile compared to LFCR. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs AQST Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, AQST has a market cap of 236.40M. Regarding current trading prices, CPHI is priced at $2.23, while AQST trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas AQST's P/E ratio is -4.10. In terms of profitability, CPHI's ROE is -0.45%, compared to AQST's ROE of +1.07%. Regarding short-term risk, CPHI is more volatile compared to AQST. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs TYHT Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, TYHT has a market cap of 229.17M. Regarding current trading prices, CPHI is priced at $2.23, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas TYHT's P/E ratio is -1.61. In terms of profitability, CPHI's ROE is -0.45%, compared to TYHT's ROE of -1.41%. Regarding short-term risk, CPHI is more volatile compared to TYHT. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs REPH Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, REPH has a market cap of 177.42M. Regarding current trading prices, CPHI is priced at $2.23, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas REPH's P/E ratio is -8.04. In terms of profitability, CPHI's ROE is -0.45%, compared to REPH's ROE of -0.15%. Regarding short-term risk, CPHI is more volatile compared to REPH. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs OGI Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, OGI has a market cap of 171.71M. Regarding current trading prices, CPHI is priced at $2.23, while OGI trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas OGI's P/E ratio is 10.46. In terms of profitability, CPHI's ROE is -0.45%, compared to OGI's ROE of +0.05%. Regarding short-term risk, CPHI is less volatile compared to OGI. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs DERM Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, DERM has a market cap of 160.34M. Regarding current trading prices, CPHI is priced at $2.23, while DERM trades at $6.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas DERM's P/E ratio is -9.63. In terms of profitability, CPHI's ROE is -0.45%, compared to DERM's ROE of -0.52%. Regarding short-term risk, CPHI is less volatile compared to DERM. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs ESPR Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, ESPR has a market cap of 158.92M. Regarding current trading prices, CPHI is priced at $2.23, while ESPR trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas ESPR's P/E ratio is -0.94. In terms of profitability, CPHI's ROE is -0.45%, compared to ESPR's ROE of +0.40%. Regarding short-term risk, CPHI is more volatile compared to ESPR. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs BIOA Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, BIOA has a market cap of 141.25M. Regarding current trading prices, CPHI is priced at $2.23, while BIOA trades at $3.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas BIOA's P/E ratio is -1.99. In terms of profitability, CPHI's ROE is -0.45%, compared to BIOA's ROE of -0.38%. Regarding short-term risk, CPHI is more volatile compared to BIOA. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs THTX Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, THTX has a market cap of 120.01M. Regarding current trading prices, CPHI is priced at $2.23, while THTX trades at $2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas THTX's P/E ratio is -37.29. In terms of profitability, CPHI's ROE is -0.45%, compared to THTX's ROE of +0.16%. Regarding short-term risk, CPHI is more volatile compared to THTX. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs SCTL Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, SCTL has a market cap of 116.13M. Regarding current trading prices, CPHI is priced at $2.23, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas SCTL's P/E ratio is -7.86. In terms of profitability, CPHI's ROE is -0.45%, compared to SCTL's ROE of -0.15%. Regarding short-term risk, CPHI is more volatile compared to SCTL. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs PROC Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, PROC has a market cap of 113.95M. Regarding current trading prices, CPHI is priced at $2.23, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas PROC's P/E ratio is 1.53. In terms of profitability, CPHI's ROE is -0.45%, compared to PROC's ROE of -2.22%. Regarding short-term risk, CPHI is more volatile compared to PROC. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs OPTN Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, OPTN has a market cap of 98.13M. Regarding current trading prices, CPHI is priced at $2.23, while OPTN trades at $9.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas OPTN's P/E ratio is -4.51. In terms of profitability, CPHI's ROE is -0.45%, compared to OPTN's ROE of +0.64%. Regarding short-term risk, CPHI is more volatile compared to OPTN. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs ZOM Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, ZOM has a market cap of 95.35M. Regarding current trading prices, CPHI is priced at $2.23, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas ZOM's P/E ratio is -1.62. In terms of profitability, CPHI's ROE is -0.45%, compared to ZOM's ROE of -0.55%. Regarding short-term risk, CPHI is more volatile compared to ZOM. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs IRWD Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, IRWD has a market cap of 92.24M. Regarding current trading prices, CPHI is priced at $2.23, while IRWD trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas IRWD's P/E ratio is -3.00. In terms of profitability, CPHI's ROE is -0.45%, compared to IRWD's ROE of +0.01%. Regarding short-term risk, CPHI is less volatile compared to IRWD. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs CRDL Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, CRDL has a market cap of 91.72M. Regarding current trading prices, CPHI is priced at $2.23, while CRDL trades at $1.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas CRDL's P/E ratio is -3.08. In terms of profitability, CPHI's ROE is -0.45%, compared to CRDL's ROE of -2.08%. Regarding short-term risk, CPHI is more volatile compared to CRDL. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs GRVI Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, GRVI has a market cap of 88.91M. Regarding current trading prices, CPHI is priced at $2.23, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas GRVI's P/E ratio is 26.05. In terms of profitability, CPHI's ROE is -0.45%, compared to GRVI's ROE of -5.25%. Regarding short-term risk, CPHI is less volatile compared to GRVI. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs INCR Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, INCR has a market cap of 71.45M. Regarding current trading prices, CPHI is priced at $2.23, while INCR trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas INCR's P/E ratio is -3.69. In terms of profitability, CPHI's ROE is -0.45%, compared to INCR's ROE of -0.07%. Regarding short-term risk, CPHI is more volatile compared to INCR. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs CPIX Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, CPIX has a market cap of 70.47M. Regarding current trading prices, CPHI is priced at $2.23, while CPIX trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas CPIX's P/E ratio is -19.62. In terms of profitability, CPHI's ROE is -0.45%, compared to CPIX's ROE of -0.13%. Regarding short-term risk, CPHI is less volatile compared to CPIX. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs ZYNE Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, ZYNE has a market cap of 70.12M. Regarding current trading prices, CPHI is priced at $2.23, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, CPHI's ROE is -0.45%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, CPHI is more volatile compared to ZYNE. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs SSIC Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, SSIC has a market cap of 66.72M. Regarding current trading prices, CPHI is priced at $2.23, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas SSIC's P/E ratio is 11.93. In terms of profitability, CPHI's ROE is -0.45%, compared to SSIC's ROE of +0.03%. Regarding short-term risk, CPHI is more volatile compared to SSIC. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs ASRT Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, ASRT has a market cap of 63.77M. Regarding current trading prices, CPHI is priced at $2.23, while ASRT trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas ASRT's P/E ratio is -2.08. In terms of profitability, CPHI's ROE is -0.45%, compared to ASRT's ROE of -0.24%. Regarding short-term risk, CPHI is less volatile compared to ASRT. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs VLNS Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, VLNS has a market cap of 61.46M. Regarding current trading prices, CPHI is priced at $2.23, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas VLNS's P/E ratio is -1.03. In terms of profitability, CPHI's ROE is -0.45%, compared to VLNS's ROE of N/A. Regarding short-term risk, CPHI is more volatile compared to VLNS. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs JUPW Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, JUPW has a market cap of 49.33M. Regarding current trading prices, CPHI is priced at $2.23, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas JUPW's P/E ratio is -2.41. In terms of profitability, CPHI's ROE is -0.45%, compared to JUPW's ROE of -9.40%. Regarding short-term risk, CPHI is less volatile compared to JUPW. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs QLI Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, QLI has a market cap of 38.68M. Regarding current trading prices, CPHI is priced at $2.23, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas QLI's P/E ratio is -4.92. In terms of profitability, CPHI's ROE is -0.45%, compared to QLI's ROE of -0.16%. Regarding short-term risk, CPHI is more volatile compared to QLI. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs RMTI Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, RMTI has a market cap of 34.52M. Regarding current trading prices, CPHI is priced at $2.23, while RMTI trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas RMTI's P/E ratio is -33.67. In terms of profitability, CPHI's ROE is -0.45%, compared to RMTI's ROE of -0.01%. Regarding short-term risk, CPHI is more volatile compared to RMTI. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs HEXO Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, HEXO has a market cap of 31.24M. Regarding current trading prices, CPHI is priced at $2.23, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas HEXO's P/E ratio is -0.26. In terms of profitability, CPHI's ROE is -0.45%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, CPHI is more volatile compared to HEXO. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs SCYX Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, SCYX has a market cap of 30.83M. Regarding current trading prices, CPHI is priced at $2.23, while SCYX trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas SCYX's P/E ratio is -1.80. In terms of profitability, CPHI's ROE is -0.45%, compared to SCYX's ROE of -0.48%. Regarding short-term risk, CPHI is less volatile compared to SCYX. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs EGRX Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, EGRX has a market cap of 25.14M. Regarding current trading prices, CPHI is priced at $2.23, while EGRX trades at $1.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas EGRX's P/E ratio is 2.28. In terms of profitability, CPHI's ROE is -0.45%, compared to EGRX's ROE of +0.17%. Regarding short-term risk, CPHI is less volatile compared to EGRX. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs KALA Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, KALA has a market cap of 23.68M. Regarding current trading prices, CPHI is priced at $2.23, while KALA trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas KALA's P/E ratio is -0.36. In terms of profitability, CPHI's ROE is -0.45%, compared to KALA's ROE of -3.69%. Regarding short-term risk, CPHI is less volatile compared to KALA. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs CYTH Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, CYTH has a market cap of 23.59M. Regarding current trading prices, CPHI is priced at $2.23, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas CYTH's P/E ratio is -0.80. In terms of profitability, CPHI's ROE is -0.45%, compared to CYTH's ROE of +7.50%. Regarding short-term risk, CPHI is more volatile compared to CYTH. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs QNTM Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, QNTM has a market cap of 23.57M. Regarding current trading prices, CPHI is priced at $2.23, while QNTM trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas QNTM's P/E ratio is -0.78. In terms of profitability, CPHI's ROE is -0.45%, compared to QNTM's ROE of N/A. Regarding short-term risk, CPHI is less volatile compared to QNTM. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs DRRX Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, DRRX has a market cap of 19.56M. Regarding current trading prices, CPHI is priced at $2.23, while DRRX trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas DRRX's P/E ratio is -1.05. In terms of profitability, CPHI's ROE is -0.45%, compared to DRRX's ROE of -0.93%. Regarding short-term risk, CPHI is less volatile compared to DRRX. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs SXTC Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, SXTC has a market cap of 19.23M. Regarding current trading prices, CPHI is priced at $2.23, while SXTC trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas SXTC's P/E ratio is 0.01. In terms of profitability, CPHI's ROE is -0.45%, compared to SXTC's ROE of +0.47%. Regarding short-term risk, CPHI is less volatile compared to SXTC. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs GELS Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, GELS has a market cap of 18.03M. Regarding current trading prices, CPHI is priced at $2.23, while GELS trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas GELS's P/E ratio is -7.96. In terms of profitability, CPHI's ROE is -0.45%, compared to GELS's ROE of N/A. Regarding short-term risk, CPHI is less volatile compared to GELS. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs TXMD Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, TXMD has a market cap of 17.36M. Regarding current trading prices, CPHI is priced at $2.23, while TXMD trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas TXMD's P/E ratio is -7.50. In terms of profitability, CPHI's ROE is -0.45%, compared to TXMD's ROE of -0.08%. Regarding short-term risk, CPHI is more volatile compared to TXMD. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs PRPH Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, PRPH has a market cap of 16.21M. Regarding current trading prices, CPHI is priced at $2.23, while PRPH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas PRPH's P/E ratio is -0.16. In terms of profitability, CPHI's ROE is -0.45%, compared to PRPH's ROE of -1.59%. Regarding short-term risk, CPHI is less volatile compared to PRPH. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs FLGC Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, FLGC has a market cap of 15.25M. Regarding current trading prices, CPHI is priced at $2.23, while FLGC trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas FLGC's P/E ratio is -0.52. In terms of profitability, CPHI's ROE is -0.45%, compared to FLGC's ROE of -2.55%. Regarding short-term risk, CPHI is less volatile compared to FLGC. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs ACRX Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, ACRX has a market cap of 14.58M. Regarding current trading prices, CPHI is priced at $2.23, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas ACRX's P/E ratio is -0.31. In terms of profitability, CPHI's ROE is -0.45%, compared to ACRX's ROE of -2.49%. Regarding short-term risk, CPHI is less volatile compared to ACRX. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs SISI Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, SISI has a market cap of 14.41M. Regarding current trading prices, CPHI is priced at $2.23, while SISI trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas SISI's P/E ratio is -0.01. In terms of profitability, CPHI's ROE is -0.45%, compared to SISI's ROE of -1.41%. Regarding short-term risk, CPHI is less volatile compared to SISI. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs AYTU Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, AYTU has a market cap of 13.14M. Regarding current trading prices, CPHI is priced at $2.23, while AYTU trades at $2.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas AYTU's P/E ratio is -1.02. In terms of profitability, CPHI's ROE is -0.45%, compared to AYTU's ROE of +0.05%. Regarding short-term risk, CPHI is less volatile compared to AYTU. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs COSM Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, COSM has a market cap of 11.71M. Regarding current trading prices, CPHI is priced at $2.23, while COSM trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas COSM's P/E ratio is -0.37. In terms of profitability, CPHI's ROE is -0.45%, compared to COSM's ROE of -0.51%. Regarding short-term risk, CPHI is more volatile compared to COSM. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs AGRX Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, AGRX has a market cap of 10.43M. Regarding current trading prices, CPHI is priced at $2.23, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas AGRX's P/E ratio is -0.89. In terms of profitability, CPHI's ROE is -0.45%, compared to AGRX's ROE of +1.04%. Regarding short-term risk, CPHI is more volatile compared to AGRX. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs TLPH Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, TLPH has a market cap of 10.33M. Regarding current trading prices, CPHI is priced at $2.23, while TLPH trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas TLPH's P/E ratio is -1.01. In terms of profitability, CPHI's ROE is -0.45%, compared to TLPH's ROE of -1.29%. Regarding short-term risk, CPHI is less volatile compared to TLPH. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs BFRIW Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, BFRIW has a market cap of 8.26M. Regarding current trading prices, CPHI is priced at $2.23, while BFRIW trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas BFRIW's P/E ratio is -0.14. In terms of profitability, CPHI's ROE is -0.45%, compared to BFRIW's ROE of -2.16%. Regarding short-term risk, CPHI is more volatile compared to BFRIW. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs NLTX Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, NLTX has a market cap of 8.20M. Regarding current trading prices, CPHI is priced at $2.23, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas NLTX's P/E ratio is -0.28. In terms of profitability, CPHI's ROE is -0.45%, compared to NLTX's ROE of -0.49%. Regarding short-term risk, CPHI is more volatile compared to NLTX. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs LCI Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, LCI has a market cap of 7.38M. Regarding current trading prices, CPHI is priced at $2.23, while LCI trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas LCI's P/E ratio is -0.04. In terms of profitability, CPHI's ROE is -0.45%, compared to LCI's ROE of +1.66%. Regarding short-term risk, CPHI is less volatile compared to LCI. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.
CPHI vs BGXX Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, BGXX has a market cap of 7.26M. Regarding current trading prices, CPHI is priced at $2.23, while BGXX trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas BGXX's P/E ratio is -0.76. In terms of profitability, CPHI's ROE is -0.45%, compared to BGXX's ROE of -0.88%. Regarding short-term risk, CPHI is more volatile compared to BGXX. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs ADMP Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, ADMP has a market cap of 7.25M. Regarding current trading prices, CPHI is priced at $2.23, while ADMP trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas ADMP's P/E ratio is -0.08. In terms of profitability, CPHI's ROE is -0.45%, compared to ADMP's ROE of +0.00%. Regarding short-term risk, CPHI is more volatile compared to ADMP. This indicates potentially higher risk in terms of short-term price fluctuations for CPHI.
CPHI vs IXHL Comparison
CPHI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CPHI stands at 7.27M. In comparison, IXHL has a market cap of 7.16M. Regarding current trading prices, CPHI is priced at $2.23, while IXHL trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CPHI currently has a P/E ratio of -0.78, whereas IXHL's P/E ratio is -0.18. In terms of profitability, CPHI's ROE is -0.45%, compared to IXHL's ROE of -2.03%. Regarding short-term risk, CPHI is less volatile compared to IXHL. This indicates potentially lower risk in terms of short-term price fluctuations for CPHI.